Entolimod, an Adjuvant for Vaccine Augmentation
Clinical trial NCT03063736 · COMPLETED
Trial details
- NCT number
- NCT03063736
- Sponsor
- Baylor College of Medicine
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-08
- Primary completion
- 2018-03-09
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.